Open Access

What is the evidence for empagliflozin in HF?

Topic: Chronic Heart Failure
Sponsored by Boehringer Ingelheim and Eli Lilly and Company

Congress Presentation

About the speaker

Professor Javed Butler

Baylor Scott and White Health, Dallas (United States of America)
105 presentations
14 followers

3 more presentations in this session

Welcome and introduction.

Speaker: Professor A. Stewart Coats (Sydney, AU)

Thumbnail

Using empagliflozin for HFpEF treatment - what does this look like in practice?

Speaker: Doctor S. Zieroth (Winnipeg, CA)

Thumbnail

Panel discussion and close.

Speaker: Professor A. Stewart Coats (Sydney, AU)

Thumbnail

Access the full session

A new era for HFpEF – Exploring the role of empagliflozin in practice

Speakers: Professor J. Butler, Professor A. Stewart Coats, Doctor S. Zieroth, Professor A. Stewart Coats
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb